ArticleScientific reports2025
Automated image segmentation for accelerated nanoparticle characterization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cancer Drug Delivery with Nanoparticles and Biomolecules: Stimuli-Responsive, Theranostic, and AI-Guided Approaches.Materials (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recent developments in materials science have made it possible to synthesize millions of individual nanoparticles on a chip. However, many steps in the characterization process still require extensive human input. To address this challenge, we present an automated image processing pipeline that optimizes high-throughput nanoparticle characterization using intelligent image segmentation and coordinate generation. The proposed method can rapidly analyze each image and return optimized acquisition coordinates suitable for multiple analytical STEM techniques, including 4D-STEM, EELS, and EDS. The pipeline employs computer vision and unsupervised learning to remove the image background, segment the particle into areas of interest, and generate acquisition coordinates. This approach eliminates the need for uniform grid sampling, focusing data collection on regions of interest. We validated our approach using a diverse dataset of over 900 high-resolution grayscale nanoparticle images, achieving a 96.0% success rate based on expert-validated criteria. Using established 4D-STEM acquisition times as a baseline, our method demonstrates a 25.0 to 29.1-fold reduction in total processing time. By automating this crucial preprocessing step and optimizing data acquisition, our pipeline significantly accelerates materials characterization workflows while reducing unnecessary data collection.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.